LPL Financial
TARS icon

LPL Financial’s Tarsus Pharmaceuticals TARS Stock Holding History

LPL Financial’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$895K Sell
14,226
-302
-2% -$19.3K ﹤0.01% 4517
2026
Q1 		$1.02M Sell
14,528
-755
-5% -$52.8K ﹤0.01% 4158
2025
Q4 		$1.25M Sell
15,283
-1,994
-12% -$149K ﹤0.01% 3836
2025
Q3 		$1.03M Buy
17,277
+2,936
+20% +$145K ﹤0.01% 3980
2025
Q2 		$581K Buy
14,341
+6,316
+79% +$284K ﹤0.01% 4258
2025
Q1 		$412K Buy
8,025
+1,557
+24% +$77K ﹤0.01% 4343
2024
Q4 		$358K Sell
6,468
-5,125
-44% -$233K ﹤0.01% 4371
2024
Q3 		$381K Buy
+11,593
New +$326K ﹤0.01% 4239

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LPL Financial's TARS Position: Q2 2026 in Review

LPL Financial reduced its Tarsus Pharmaceuticals (TARS) stake by 2.1% in Q2 2026, selling an estimated $19.3K and leaving 14,226 shares worth $895K. The position accounts for ﹤0.01% of the portfolio, ranked #4517.

LPL Financial first reported a position in TARS in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.25M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • LPL Financial held 14,226 shares of Tarsus Pharmaceuticals worth $895K as of Q2 2026.
  • LPL Financial sold 302 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $19.3K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4517 holding.
  • LPL Financial first reported a position in Tarsus Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • LPL Financial's Tarsus Pharmaceuticals position peaked at $1.25M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.